CANC ETF
Tema Oncology ETF
RVMD is CANC's largest holding at 5.34% of the fund as of Sep 2, 2026. CANC is Tema Oncology ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | R | Revolution Medicines IncHealth Care · Biotechnology | 5.34% | 5.3% | 54,887 | $11.48M | Health Care | Biotechnology |
| 2 | C | Cogent Biosciences IncHealth Care · Biotechnology | 4.87% | 10.2% | 303,132 | $10.48M | Health Care | Biotechnology |
| Sector and industry · Pro | ||||||||
| 3 | M | Merck & Company Inc | 4.62% | 14.8% | 65,538 | $9.94M | ||
| 4 | L | Eli Lilly & Co. | 4.37% | 19.2% | 8,097 | $9.39M | ||
| 5 | N | Novartis Ag - | 3.97% | 23.2% | 52,786 | $8.53M | ||
| 6 | B | Bristol-Myers Squibb Co. | 3.57% | 26.7% | 113,617 | $7.69M | ||
| 7 | A | AbbVie Inc. | 3.35% | 30.1% | 27,506 | $7.20M | ||
| 8 | O | Beigene, Ltd. Adr | 3.16% | 33.3% | 18,783 | $6.80M | ||
| 9 | J | Johnson & Johnson - | 3.16% | 36.4% | 24,705 | $6.80M | ||
| 10 | I | Immunome Inc | 2.95% | 39.4% | 232,377 | $6.35M | ||
| 11 | R | Roche Holding Ag (Adr) | 2.95% | 42.3% | 117,767 | $6.34M | ||
| 12 | — | Genmab A/s ADR | 2.94% | 45.3% | 184,482 | $6.31M | ||
| 13 | H | Halozyme Therapeutics Inc | 2.94% | 48.2% | 57,674 | $6.32M | ||
| 14 | E | Exelixis Inc | 2.78% | 51.0% | 102,082 | $5.97M | ||
| 15 | C | Cg Oncology Inc | 2.71% | 53.7% | 78,021 | $5.82M | ||
| 16 | I | Ideaya Biosciences Inc | 2.67% | 56.4% | 143,144 | $5.75M | ||
| 17 | E | Enliven Therapeutics Inc | 2.66% | 59.0% | 97,054 | $5.73M | ||
| 18 | B | Bridgebio Pharma Inc_None_0 | 2.59% | 61.6% | 72,853 | $5.57M | ||
| 19 | A | Amgen Inc. | 2.09% | 63.7% | 10,157 | $4.50M | ||
| 20 | L | Legend Biotech Corp-adr | 2.03% | 65.7% | 199,149 | $4.36M | ||
| 21 | E | Erasca Inc. | 2.02% | 67.7% | 265,462 | $4.35M | ||
| 22 | Z | Zai Lab Ltd | 2.00% | 69.7% | 162,268 | $4.30M | ||
| 23 | — | AstraZeneca PLC | 1.96% | 71.7% | 26,142 | $4.22M | ||
| 24 | C | Celcuity Inc | 1.93% | 73.6% | 43,098 | $4.15M | ||
| 25 | R | Relay Therapeutics Inc | 1.90% | 75.5% | 221,256 | $4.10M | ||
| 26 | — | Zymeworks Inc. | 1.61% | 77.1% | 111,287 | $3.46M | ||
| 27 | I | Iovance Biotherapeutics Inc | 1.53% | 78.7% | 381,012 | $3.28M | ||
| 28 | N | Nuvation Bio Inc | 1.35% | 80.0% | 419,197 | $2.91M | ||
| 29 | U | Urogen Pharma Ltd Com Ils0.01 | 1.27% | 81.3% | 61,654 | $2.74M | ||
| 30 | R | Arcus Biosciences Inc | 1.22% | 82.5% | 87,601 | $2.61M | ||
| 31 | K | Kura Oncology Inc | 1.05% | 83.6% | 172,438 | $2.26M | ||
| 32 | G | Gilead Sciences | 1.03% | 84.6% | 14,736 | $2.20M | ||
| 33 | S | Summit Therapeutics | 1.02% | 85.6% | 150,956 | $2.20M | ||
| 34 | T | Tyra Biosciences Inc | 1.00% | 86.6% | 85,845 | $2.16M | ||
| 35 | C | Corvus Pharmaceuticals Inc | 0.95% | 87.6% | 143,598 | $2.04M | ||
| 36 | N | Natera Inc | 0.93% | 88.5% | 6,120 | $1.99M | ||
| 37 | A | Anaptysbio Inc | 0.86% | 89.4% | 32,945 | $1.84M | ||
| 38 | R | Replimune Group Inc | 0.81% | 90.2% | 109,079 | $1.74M | ||
| 39 | I | Immatics Nv | 0.80% | 91.0% | 180,721 | $1.72M | ||
| 40 | — | Immunocore Holdings Ltd Adr | 0.79% | 91.8% | 45,176 | $1.69M | ||
| 41 | C | Cullinan Therapeutics Inc | 0.69% | 92.4% | 66,187 | $1.48M | ||
| 42 | O | ORIC Pharmaceuticals, Inc. | 0.68% | 93.1% | 111,490 | $1.46M | ||
| 43 | G | Guardant Health, Inc | 0.67% | 93.8% | 8,824 | $1.44M | ||
| 44 | F | First Am Treas Obli-X | 0.61% | 94.4% | 1,319,262 | $1.32M | ||
| 45 | T | Tango Therapeutics Inc. | 0.58% | 95.0% | 56,146 | $1.25M | ||
| 46 | C | Candel Therapeutics Inc. | 0.53% | 95.5% | 86,865 | $1.15M | ||
| 47 | S | Syndax Pharmaceuticals Inc | 0.53% | 96.0% | 55,298 | $1.15M | ||
| 48 | J | Janux Therapeutics Inc | 0.50% | 96.5% | 54,283 | $1.07M | ||
| 49 | C | Cytomx Therapeutics Inc | 0.42% | 97.0% | 242,819 | $903.3K | ||
| 50 | O | Olema Pharmaceuticals Inc | 0.42% | 97.4% | 84,045 | $910.2K | ||
| More holdings · Pro | ||||||||
CANC ETF All Holdings
CANC holdings total 58 positions. The top 10 holdings account for 39.4% of the fund, led by Revolution Medicines Inc at 5.3%, Cogent Biosciences Inc at 4.9%, Merck & Company Inc at 4.6%.
CANC portfolio concentration is moderate, with the top 10 representing 39.4% of total assets. The largest sector exposure is Health Care at 90.1%.
CANC sectors provide a detailed breakdown. CANC overlap shows how holdings compare to other funds in your portfolio.
CANC ETF Holdings
59 of 58 holdings
- 1
Revolution Medicines Inc
RVMDHealth Care5.34% - 2
Cogent Biosciences Inc
COGTHealth Care4.87% - 3
Merck & Company Inc
MRKHealth Care4.62% - 4
Eli Lilly & Co.
LLYHealth Care4.37% - 5
Novartis Ag - Common
NOVN:SMUnknown3.97% - 6
Bristol-Myers Squibb Co.
BMYHealth Care3.57% - 7
Abbvie Inc.
ABBVHealth Care3.35% - 8
Beigene, Ltd. Adr
BGNEHealth Care3.16% - 9
Johnson & Johnson - Common
JNJHealth Care3.16% - 10
Immunome Inc
IMNMHealth Care2.95% - 11
Roche Holding Ag (Adr)
RHHBY:SMUnknown2.95% - 12
Genmab A/s ADR
GMAB:COHealth Care2.94% - 13
Halozyme Therapeutics Inc
HALOHealth Care2.94% - 14
Exelixis Inc
EXELHealth Care2.78% - 15
Cg Oncology Inc
CGONHealth Care2.71% - 16
Ideaya Biosciences Inc
IDYAHealth Care2.67% - 17
Enliven Therapeutics Inc
ELVNHealth Care2.66% - 18
Bridgebio Pharma Inc_None_0
BBIOHealth Care2.59% - 19
Amgen Inc.
AMGNHealth Care2.09% - 20
LEGEND BIOTECH CORP-ADR
LEGNHealth Care2.03% - 21
Erasca Inc.
ERASHealth Care2.02% - 22
Zai Lab Ltd
ZLABHealth Care2.00% - 23
AstraZeneca PLC
AZN:LNUnknown1.96% - 24
Celcuity Inc Com
CELCHealth Care1.93% - 25
Relay Therapeutics Inc
RLAYHealth Care1.90% - 26
Zymeworks Inc. Common Stock
ZYME:CAHealth Care1.61% - 27
Iovance Biotherapeutics Inc
IOVAHealth Care1.53% - 28
Nuvation Bio Inc
NUVBHealth Care1.35% - 29
Urogen Pharma Ltd Com Ils0.01
URGNHealth Care1.27% - 30
Arcus Biosciences Inc
RCUSHealth Care1.22% - 31
Kura Oncology Inc
KURAHealth Care1.05% - 32
Gilead Sciences
GILDHealth Care1.03% - 33
Summit Therapeutics
SMMTHealth Care1.02% - 34
Tyra Biosciences Inc
TYRAHealth Care1.00% - 35
Corvus Pharmaceuticals Inc
CRVSHealth Care0.95% - 36
Natera Inc
NTRAHealth Care0.93% - 37
Anaptysbio Inc
ANABHealth Care0.86% - 38
Replimune Group Inc Com
REPLHealth Care0.81% - 39
Immatics Nv
4A3:BEHealth Care0.80% - 40
Immunocore Holdings Ltd Adr
IMCR:LNHealth Care0.79% - 41
Cullinan Therapeutics Inc
CGEMHealth Care0.69% - 42
ORIC Pharmaceuticals, Inc.
ORICHealth Care0.68% - 43
Guardant Health, Inc
GHHealth Care0.67% - 44
First Am Treas Obli-X
FXFXXFinancials0.61% - 45
Tango Therapeutics Inc.
TNGXHealth Care0.58% - 46
Candel Therapeutics Inc.
CADLHealth Care0.53% - 47
Syndax Pharmaceuticals Inc
SNDXHealth Care0.53% - 48
Janux Therapeutics Inc
JANXHealth Care0.50% - 49
Cytomx Therapeutics Inc
CTMXHealth Care0.42% - 50
Olema Pharmaceuticals Inc
OLMAHealth Care0.42% - 51
Bicara Therapeutics, Inc.
BCAXHealth Care0.41% - 52
BRIDGEBIO ONCOLOGY THERAPEUTICS IN
BBOTUnknown0.41% - 53
First Tracks Biotherapeutics, Inc.
TRAXUnknown0.41% - 54
Inhibrx Biosciences Inc
INBXHealth Care0.41% - 55
Arvinas Inc
ARVNHealth Care0.40% - 56
Moderna therapeutics
MRNAHealth Care0.37% - 57
ARRIVENT BIOPHARMA INC
AVBPHealth Care0.31% - 58
Amani Gold Ltd
ANL:AUUnknown0.30% - 59
Autolus Therapeutics Ltd. Adr
AUTL:LNHealth Care0.28%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Revolution Medicines Inc | RVMD | 5.340% | ||
| 2 | Cogent Biosciences Inc | COGT | 4.870% | ||
| 3 | Merck & Company Inc | MRK | 4.620% | ||
| 4 | Eli Lilly & Co. | LLY | 4.370% | ||
| 5 | Novartis Ag - Common | NOVN:SM | 3.970% | ||
| 6 | Bristol-Myers Squibb Co. | BMY | 3.570% | ||
| 7 | Abbvie Inc. | ABBV | 3.350% | ||
| 8 | Beigene, Ltd. Adr | BGNE | 3.160% | ||
| 9 | Johnson & Johnson - Common | JNJ | 3.160% | ||
| 10 | Immunome Inc | IMNM | 2.950% | ||
| 11 | Roche Holding Ag (Adr) | RHHBY:SM | 2.950% | ||
| 12 | Genmab A/s ADR | GMAB:CO | 2.940% | ||
| 13 | Halozyme Therapeutics Inc | HALO | 2.940% | ||
| 14 | Exelixis Inc | EXEL | 2.780% | ||
| 15 | Cg Oncology Inc | CGON | 2.710% | ||
| 16 | Ideaya Biosciences Inc | IDYA | 2.670% | ||
| 17 | Enliven Therapeutics Inc | ELVN | 2.660% | ||
| 18 | Bridgebio Pharma Inc_None_0 | BBIO | 2.590% | ||
| 19 | Amgen Inc. | AMGN | 2.090% | ||
| 20 | LEGEND BIOTECH CORP-ADR | LEGN | 2.030% | ||
| 21 | Erasca Inc. | ERAS | 2.020% | ||
| 22 | Zai Lab Ltd | ZLAB | 2.000% | ||
| 23 | AstraZeneca PLC | AZN:LN | 1.960% | ||
| 24 | Celcuity Inc Com | CELC | 1.930% | ||
| 25 | Relay Therapeutics Inc | RLAY | 1.900% | ||
| 26 | Zymeworks Inc. Common Stock | ZYME:CA | 1.610% | ||
| 27 | Iovance Biotherapeutics Inc | IOVA | 1.530% | ||
| 28 | Nuvation Bio Inc | NUVB | 1.350% | ||
| 29 | Urogen Pharma Ltd Com Ils0.01 | URGN | 1.270% | ||
| 30 | Arcus Biosciences Inc | RCUS | 1.220% | ||
| 31 | Kura Oncology Inc | KURA | 1.050% | ||
| 32 | Gilead Sciences | GILD | 1.030% | ||
| 33 | Summit Therapeutics | SMMT | 1.020% | ||
| 34 | Tyra Biosciences Inc | TYRA | 1.000% | ||
| 35 | Corvus Pharmaceuticals Inc | CRVS | 0.950% | ||
| 36 | Natera Inc | NTRA | 0.930% | ||
| 37 | Anaptysbio Inc | ANAB | 0.860% | ||
| 38 | Replimune Group Inc Com | REPL | 0.810% | ||
| 39 | Immatics Nv | 4A3:BE | 0.800% | ||
| 40 | Immunocore Holdings Ltd Adr | IMCR:LN | 0.790% | ||
| 41 | Cullinan Therapeutics Inc | CGEM | 0.690% | ||
| 42 | ORIC Pharmaceuticals, Inc. | ORIC | 0.680% | ||
| 43 | Guardant Health, Inc | GH | 0.670% | ||
| 44 | First Am Treas Obli-X | FXFXX | 0.610% | ||
| 45 | Tango Therapeutics Inc. | TNGX | 0.580% | ||
| 46 | Candel Therapeutics Inc. | CADL | 0.530% | ||
| 47 | Syndax Pharmaceuticals Inc | SNDX | 0.530% | ||
| 48 | Janux Therapeutics Inc | JANX | 0.500% | ||
| 49 | Cytomx Therapeutics Inc | CTMX | 0.420% | ||
| 50 | Olema Pharmaceuticals Inc | OLMA | 0.420% | ||
| 51 | Bicara Therapeutics, Inc. | BCAX | 0.410% | ||
| 52 | BRIDGEBIO ONCOLOGY THERAPEUTICS IN | BBOT | 0.410% | ||
| 53 | First Tracks Biotherapeutics, Inc. | TRAX | 0.410% | ||
| 54 | Inhibrx Biosciences Inc | INBX | 0.410% | ||
| 55 | Arvinas Inc | ARVN | 0.400% | ||
| 56 | Moderna therapeutics | MRNA | 0.370% | ||
| 57 | ARRIVENT BIOPHARMA INC | AVBP | 0.310% | ||
| 58 | Amani Gold Ltd | ANL:AU | 0.300% | ||
| 59 | Autolus Therapeutics Ltd. Adr | AUTL:LN | 0.280% |













































